<DOC>
	<DOCNO>NCT00065221</DOCNO>
	<brief_summary>This trial determine safety efficacy ginger reduce prevalence severity chemotherapy induce nausea vomiting .</brief_summary>
	<brief_title>Ginger Control Chemotherapy Induced Nausea Vomiting</brief_title>
	<detailed_description>Chemotherapy induce nausea vomit significantly reduce patient ' quality life , increase fatigue , anxiety , increase cost health care delivery . Ginger ( Zingiber officinalis ) already use traditional folk medicine treat nausea vomit various population . Ginger 's ability block 5-HT3 receptor free-radical scavenge intestine suggest may beneficial reduce prevalence severity chemotherapy induce nausea vomiting . Despite ginger 's possible benefit reduce prevalence severity chemotherapy induce nausea vomiting , dose and/or safety study perform . This study ass efficacy safety two dose level ( 1000 mg , 2000 mg , orally/day ) Zingiber officinalis extract ( standardized 5 % gingerol ) patient undergo chemotherapy ( cisplastin adriamycin ) experience least one episode chemotherapy induce nausea vomit despite optimal conventional medical therapy . The primary aim study determine efficacious dose powder ginger-root reduce prevalence severity acute nausea vomiting . Secondary aim study include ( 1 ) determination efficacious dose powder ginger-root reduce prevalence severity delay nausea vomit ; ( 2 ) assessment safety different dose oral powdered ginger root patient receive chemotherapy ; ( 3 ) determination study participant discern receive placebo ginger . Participants receive either adriamycin cisplatin cancer relate treatment randomize receive one two dos powder ginger placebo immediately prior chemotherapy infusion . Participants follow 72 hour infusion order ass frequency severity nausea vomit . Baseline 72 hour post chemotherapy lab use assess safety profile ginger .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>Inclusion criterion : Confirmed diagnosis cancer currently receive chemotherapy Currently treat chemotherapeutic agent dose , experience nausea and/or vomit previous round chemothearpy Scheduled receive 5HT3 receptor antagonist antiemetic : ondansetron ( Zofran速 ) granistron ( Kytril速 ) , tropisetron ( Navoban速 ) dolasetron mesylate ( Anzemet速 ) , palanosetron ( Alozi ) and/or NK1 antagonist aprepitant ( Emend ) Must able swallow capsule Must able understand English Spanish , complete questionnaire English Spanish Women childbearing age use appropriate birth control Exclusion criterion : Chemotherapy regimens multipleday dos Clinical evidence current impend bowel obstruction symptomatic brain metastasis Concurrent radiotherapy classify high intermediate risk cause nausea vomiting ; total body irradiation , hemibody , upper abdomen , abdominalpelvic mantle , cranium , craniospinal irradiation Pregnant lactating Patients history bleed disorder ( ) experience thrombocytopenia Currently take ginger take ginger last month Have allergy ginger</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Ginger</keyword>
	<keyword>Plant preparation</keyword>
	<keyword>Herbal medicine</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Nausea</keyword>
</DOC>